Q4B-40599-44182
4 vaccinations
1 coded response
41 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 142 / NY
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2020-12-30
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities2 call case(s)
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-21
- 2021-01-26
- 2021-02-02
- 2021-02-11
- 2021-02-16
- 2021-04-06
- 2021-07-08
-
2021-09-26
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-01
- 2021-10-03
-
2021-11-07
Survey response — day 42, dose 3MedDRA: Fatigue, Patellofemoral pain syndrome, Upper-airway cough syndrome — Feeling: GoodFree text: Runny Nose, post nasal drip, fatigue for one dayMedDRA releases: 2024-11 · check-in free text available
- 2022-03-27
-
2022-05-10
Dose 4 — Pfizer-BioNTech
-
2022-05-10
Health check-in — day 0, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-06-02
- 2022-06-16
- 2022-06-23
- 2022-08-09
- 2022-11-08
- 2023-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-26 | Pfizer-BioNTech | No |
| 4 | 2022-05-10 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 priority 2/3 (triaged and no follow up)
Free text
Release 10 — day 42, dose 3
Symptoms: Runny Nose, post nasal drip, fatigue for one day
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Patellofemoral pain syndrome | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release